How much funding has Spot Biosystems raised?

Spot Biosystems has raised $40.0M in total funding, most recently a seed round.

When was Spot Biosystems founded?

Spot Biosystems was founded in 2023.

Where is Spot Biosystems headquartered?

Spot Biosystems is headquartered in Boston, United States.

What industry is Spot Biosystems in?

Spot Biosystems operates in Biotech, Healthcare.

How many employees does Spot Biosystems have?

Spot Biosystems has 11-50 employees.

Spot Biosystems

Pioneering non-viral extracellular vesicle gene therapy

Boston, United States · Founded 2023 · $40.0M raised

Biotech

Healthcare

Headquarters: Boston
Employees: 11–50
Founded: 2023
Business Model: B2B

Website: spotbiosystems.com
Total Funding: $40.0M
Last Round: $40.0M SeedJun 2026
Rounds: 1

About

Spot Biosystems is building the next generation of non-viral gene therapy using an extracellular vesicle (EV) delivery platform. Its technology enables safe, repeatable delivery of genetic medicines that viral vectors cannot carry, avoiding viral immunogenicity and toxicity. The lead program targets Duchenne muscular dystrophy and has entered human clinical trials with early signs of dystrophin restoration.

Summary

Spot Biosystems is a Biotech company based in Boston, United States, founded in 2023. It has raised $40.0M in total across 1 round, most recently a $40.0M Seed round in Jun 2026.